This Solution Provider Archive Webinar is brought to you by DIA in cooperation with Cytel.

Trial planners are under increasing pressure to ensure trials are completed on time and on budget. But far too many clinical studies take longer than expected to achieve their enrollment targets, often leading to discontinued trials, and even outright failures. How can we better predict patient recruitment milestones with sufficient confidence?
 
Join Pfizer's Chris Conklin and Cytel's Charles Liu as they examine the value of using simulation software (Cytel's Enforesys®) to aid prediction and decision-making. Using historical data and other inputs known to affect enrollment, Enforesys allows planners to make accurate, data-driven predictions of enrollment milestones. Competing strategies can be compared directly, and potential challenges flagged early. Finally, the enrollment strategy can be clearly communicated to the rest of the clinical team.

 TO REGISTER FOR THIS EVENT PLEASE CLICK HERE